Mitsubishi UFJ Asset Management’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-71,101
| Closed | -$249K | – | 1598 |
|
2024
Q3 | $249K | Sell |
71,101
-6,715
| -9% | -$23.5K | ﹤0.01% | 937 |
|
2024
Q2 | $255K | Buy |
+77,816
| New | +$255K | ﹤0.01% | 932 |
|
2023
Q4 | – | Sell |
-60,299
| Closed | -$128K | – | 1569 |
|
2023
Q3 | $128K | Buy |
60,299
+7,916
| +15% | +$16.8K | ﹤0.01% | 1059 |
|
2023
Q2 | $249K | Buy |
52,383
+39,734
| +314% | +$189K | ﹤0.01% | 1012 |
|
2023
Q1 | $72.1K | Hold |
12,649
| – | – | ﹤0.01% | 1100 |
|
2022
Q4 | $129K | Buy |
12,649
+1,597
| +14% | +$16.2K | ﹤0.01% | 1065 |
|
2022
Q3 | $248K | Sell |
11,052
-19
| -0.2% | -$426 | ﹤0.01% | 1000 |
|
2022
Q2 | $274K | Buy |
11,071
+5,511
| +99% | +$136K | ﹤0.01% | 1007 |
|
2022
Q1 | $216K | Buy |
5,560
+330
| +6% | +$12.8K | ﹤0.01% | 1043 |
|
2021
Q4 | $315K | Buy |
5,230
+1,119
| +27% | +$67.4K | ﹤0.01% | 1001 |
|
2021
Q3 | $244K | Hold |
4,111
| – | – | ﹤0.01% | 1033 |
|
2021
Q2 | $357K | Sell |
4,111
-3,047
| -43% | -$265K | ﹤0.01% | 1005 |
|
2021
Q1 | $590K | Buy |
7,158
+2,325
| +48% | +$192K | ﹤0.01% | 861 |
|
2020
Q4 | $439K | Sell |
4,833
-1,843
| -28% | -$167K | ﹤0.01% | 848 |
|
2020
Q3 | $267K | Sell |
6,676
-42
| -0.6% | -$1.68K | ﹤0.01% | 863 |
|
2020
Q2 | $230K | Sell |
6,718
-5,537
| -45% | -$190K | ﹤0.01% | 869 |
|
2020
Q1 | $272K | Buy |
12,255
+2,480
| +25% | +$55K | ﹤0.01% | 815 |
|
2019
Q4 | $187K | Buy |
9,775
+1,955
| +25% | +$37.4K | ﹤0.01% | 881 |
|
2019
Q3 | $121K | Buy |
7,820
+1,529
| +24% | +$23.7K | ﹤0.01% | 882 |
|
2019
Q2 | $128K | Sell |
6,291
-6,333
| -50% | -$129K | ﹤0.01% | 893 |
|
2019
Q1 | $222K | Buy |
12,624
+1,139
| +10% | +$20K | ﹤0.01% | 783 |
|
2018
Q4 | $151K | Sell |
11,485
-3,116
| -21% | -$41K | ﹤0.01% | 787 |
|
2018
Q3 | $238K | Buy |
+14,601
| New | +$238K | ﹤0.01% | 756 |
|